News Gilead expands CAR-T deal with MaxCyte, Precision files for ... It has been a busy month already in the field of CAR-T therapy, with Gilead expanding a partnership with MaxCyte, and Precision BioSciences filing for a $100 million IPO for its ‘off-the-sh
News NICE to reassess Pfizer blood cancer drug Company successfully appealed against rejection last summer
News Pfizer facing NICE showdown over leukaemia drug Pfizer locks horns with NICE following EU approval.
News EMA seeks input on virtual alternative to animal test EMA delivers a milestone in the replacement of animals in drug testing with the qualification of a virtual model for repeat-dose toxicity studies.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
